S. Pollard

6.3k total citations
8 papers, 98 citations indexed

About

S. Pollard is a scholar working on Oncology, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, S. Pollard has authored 8 papers receiving a total of 98 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Obstetrics and Gynecology and 3 papers in Genetics. Recurrent topics in S. Pollard's work include Estrogen and related hormone effects (3 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). S. Pollard is often cited by papers focused on Estrogen and related hormone effects (3 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). S. Pollard collaborates with scholars based in United Kingdom, Italy and New Zealand. S. Pollard's co-authors include Kamaira Philips, Mark Lansdown, Glen Clack, Michel Coibion, Simon P. Duffy, Michael Wells, Antonio Bianco, J. Cuzick, Trachette L. Jackson and Angelo Raffaele Bianco and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Human Reproduction.

In The Last Decade

S. Pollard

8 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Pollard United Kingdom 5 60 44 30 29 24 8 98
Isabell Ge Germany 6 17 0.3× 16 0.4× 47 1.6× 33 1.1× 14 0.6× 11 127
Raga Vadhi United States 3 58 1.0× 7 0.2× 35 1.2× 32 1.1× 8 0.3× 3 117
Celeste Leigh Pearce Australia 4 20 0.3× 11 0.3× 18 0.6× 30 1.0× 35 1.5× 5 101
Lindsey Beffa United States 5 10 0.2× 26 0.6× 10 0.3× 15 0.5× 34 1.4× 16 92
Lucía González Cortijo Spain 5 4 0.1× 20 0.5× 19 0.6× 10 0.3× 22 0.9× 11 51
Cecilia M. Dorfling South Africa 3 6 0.1× 59 1.3× 12 0.4× 5 0.2× 36 1.5× 3 89
Angela Jain United States 4 3 0.1× 15 0.3× 23 0.8× 11 0.4× 35 1.5× 14 68
Pater Jl Canada 6 16 0.3× 2 0.0× 56 1.9× 24 0.8× 18 0.8× 8 89
Karina Rønlund Denmark 5 12 0.2× 6 0.1× 20 0.7× 16 0.6× 5 0.2× 10 63
Giulia Cini Italy 6 19 0.3× 6 0.1× 28 0.9× 45 1.6× 7 0.3× 7 82

Countries citing papers authored by S. Pollard

Since Specialization
Citations

This map shows the geographic impact of S. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pollard more than expected).

Fields of papers citing papers by S. Pollard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pollard. The network helps show where S. Pollard may publish in the future.

Co-authorship network of co-authors of S. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pollard. A scholar is included among the top collaborators of S. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pollard. S. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mishra, Sanjay R., et al.. (2024). The effect of nickel oxide in the direct growth of MnOx on Ni foam by chemical vapor deposition. Advances in Natural Sciences Nanoscience and Nanotechnology. 15(1). 15011–15011. 1 indexed citations
2.
Pérez, David, Katrina Sharples, Reuben Broom, et al.. (2015). A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea. Supportive Care in Cancer. 23(11). 3307–3315. 8 indexed citations
3.
Harvey, V.J., Katrina Sharples, R. Isaacs, et al.. (2013). A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. Annals of Oncology. 24(7). 1828–1834. 5 indexed citations
4.
Harvey, VJ, Katrina Sharples, Randi Isaacs, et al.. (2008). A randomized phase II study comparing capecitabine (C) with C plus oral cyclophosphamide (CCy) in patients (pts) with advanced breast cancer (BC). Journal of Clinical Oncology. 26(15_suppl). 1077–1077. 1 indexed citations
5.
Burkinshaw, Roger, H. Thorpe, S. Pollard, et al.. (2006). The AZURE trial – does adjuvant zoledronic acid reduce recurrence in patients with high-risk localised breast cancer?. Bone. 38(3). 70–71. 4 indexed citations
6.
Duffy, Simon P., Mark Lansdown, Kamaira Philips, et al.. (2005). The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Human Reproduction. 21(2). 545–553. 49 indexed citations
8.
Duffy, Simon P., Trachette L. Jackson, Mark Lansdown, et al.. (2003). The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. BJOG An International Journal of Obstetrics & Gynaecology. 110(12). 1099–1106. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026